Valeant is in advanced talks to sell a big stomach-drug business to Japan’s Takeda Pharmaceutical for about $10 billion, a move that could ease pressure on Valeant over its hefty debt load.
from WSJ.com: US Business http://ift.tt/2dZG68i
via IFTTT
No comments:
Post a Comment